RCM
WST icon

Rutabaga Capital Management’s West Pharmaceutical WST Stock Holding History

Rutabaga Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-246,131
Closed -$11M – 73
2014
Q3 		$11M Buy
246,131
+8,300
+3% +$353K 1.1% 45
2014
Q2 		$10M Buy
237,831
+7,135
+3% +$306K 0.95% 51
2014
Q1 		$10.2M Buy
230,696
+4,427
+2% +$208K 0.98% 51
2013
Q4 		$11.1M Sell
226,269
-30,842
-12% -$1.44M 1.07% 46
2013
Q3 		$10.6M Sell
257,111
-16,185
-6% -$617K 1.15% 45
2013
Q2 		$9.6M Buy
+273,296
New +$8.99M 1.22% 44

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return